Top Markets
Coin of the day
Raphael Pharmaceutical Inc. Raphael Pharmaceutical Inc.

Raphael Pharmaceutical Inc.

RAPH
株式のランク #28150
Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating... Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating its efforts on discovering and clinically developing novel therapeutic solutions. These treatments primarily leverage cannabinoids and are designed to enhance patients' quality of life. Currently, the company's leading investigational drug candidate is being advanced for the management of rheumatoid arthritis. Furthermore, Raphael Pharma plans to broaden its pipeline to include more cannabinoid-based medicines aimed at various cancer types and other autoimmune conditions. The company's corporate headquarters are situated in Tel Aviv-Jaffa, Israel.
株価
$1.40
最終同期: 2026-08-18
時価総額
$28.25M
変化(1日)
0.00%
変化(1年)
536.36%
IL
取引 Raphael Pharmaceutical Inc. (RAPH)

カテゴリー

Raphael Pharmaceutical Inc.(RAPH)の配当利回りの履歴
Raphael Pharmaceutical Inc.(銘柄コード: RAPH)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Raphael Pharmaceutical Inc.(RAPH)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)